Concepedia

Roeland Lameris

RL

9

Publications

393

Citations

9

H-Index

2016

Active since

Affiliations

Amsterdam University Medical Centers(Current)

Vrije Universiteit Amsterdam

University of Amsterdam

Lava Therapeutics (Netherlands)

Albert Schweitzer Ziekenhuis

Roeland Lameris is an author at Amsterdam University Medical Centers specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2023

9

Publications

9

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

Renée C.G. de Bruin, John P. Veluchamy, Sinéad M. Lougheed et al. · OncoImmunology · 2017 · 82 citations · Full text

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma

Renée Poels, Esther Drent, Roeland Lameris et al. · International Journal of Molecular Sciences · 2021 · 65 citations · Full text

A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia

Iris de Weerdt, Roeland Lameris, Jurjen M. Ruben et al. · Clinical Cancer Research · 2021 · 52 citations · Full text

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Iris de Weerdt, Tom Hofland, Roeland Lameris et al. · Blood · 2018 · 48 citations · Full text

A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response

Roeland Lameris, Adam Shahine, Daniel G. Pellicci et al. · Nature Cancer · 2020 · 38 citations

, , +7

Rows per page

1–5 of 9